Bioactive compounds: Definition and assessment of activity

H.K. Biesalski; L.O. Dragsted; I. Elmadfa; R. Grossklaus; M.R. Müller; D. Schrenk; P. Walter; P. Weber

doi:10.1016/j.nut.2009.04.023

Bioactive compounds: Definition and assessment of activity

H.K. Biesalski, L.O. Dragsted, I. Elmadfa, R. Grossklaus, M.R. Müller, D. Schrenk, P. Walter, P. Weber

Research output: Contribution to journal › Article › Academic › peer-review

292 Citations (Scopus)

Abstract

Biomarkers and their role in evaluating efficacy and safety were the topic of the 23rd Hohenheim Consensus Meeting at the University of Hohenheim in Stuttgart. Scientists who had published and reviewed scientific and regulatory papers on the topic were invited, among them basic researchers, toxicologists, clinicians, and nutritionists. The participants were presented with 11 questions (in bold font), which were discussed and answered (in italic font) at the workshop, with the aim of summarizing the current state of knowledge on the subject. The explicatory text accompanying the short answers was produced and agreed on after the conference and was backed up by corresponding references

Original language	English
Pages (from-to)	1202-1205
Journal	Nutrition
Volume	25
Issue number	11-12
DOIs	https://doi.org/10.1016/j.nut.2009.04.023
Publication status	Published - 2009

Keywords

risk factor
disease

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.nut.2009.04.023

Cite this

@article{81de4fecf1bd4dc9b029e88a8ac34e91,

title = "Bioactive compounds: Definition and assessment of activity",

abstract = "Biomarkers and their role in evaluating efficacy and safety were the topic of the 23rd Hohenheim Consensus Meeting at the University of Hohenheim in Stuttgart. Scientists who had published and reviewed scientific and regulatory papers on the topic were invited, among them basic researchers, toxicologists, clinicians, and nutritionists. The participants were presented with 11 questions (in bold font), which were discussed and answered (in italic font) at the workshop, with the aim of summarizing the current state of knowledge on the subject. The explicatory text accompanying the short answers was produced and agreed on after the conference and was backed up by corresponding references",

keywords = "risk factor, disease",

author = "H.K. Biesalski and L.O. Dragsted and I. Elmadfa and R. Grossklaus and M.R. M{\"u}ller and D. Schrenk and P. Walter and P. Weber",

note = "ISI:000270962700020",

year = "2009",

doi = "10.1016/j.nut.2009.04.023",

language = "English",

volume = "25",

pages = "1202--1205",

journal = "Nutrition",

issn = "0899-9007",

publisher = "Elsevier",

number = "11-12",

}

TY - JOUR

T1 - Bioactive compounds: Definition and assessment of activity

AU - Biesalski, H.K.

AU - Dragsted, L.O.

AU - Elmadfa, I.

AU - Grossklaus, R.

AU - Müller, M.R.

AU - Schrenk, D.

AU - Walter, P.

AU - Weber, P.

N1 - ISI:000270962700020

PY - 2009

Y1 - 2009

N2 - Biomarkers and their role in evaluating efficacy and safety were the topic of the 23rd Hohenheim Consensus Meeting at the University of Hohenheim in Stuttgart. Scientists who had published and reviewed scientific and regulatory papers on the topic were invited, among them basic researchers, toxicologists, clinicians, and nutritionists. The participants were presented with 11 questions (in bold font), which were discussed and answered (in italic font) at the workshop, with the aim of summarizing the current state of knowledge on the subject. The explicatory text accompanying the short answers was produced and agreed on after the conference and was backed up by corresponding references

AB - Biomarkers and their role in evaluating efficacy and safety were the topic of the 23rd Hohenheim Consensus Meeting at the University of Hohenheim in Stuttgart. Scientists who had published and reviewed scientific and regulatory papers on the topic were invited, among them basic researchers, toxicologists, clinicians, and nutritionists. The participants were presented with 11 questions (in bold font), which were discussed and answered (in italic font) at the workshop, with the aim of summarizing the current state of knowledge on the subject. The explicatory text accompanying the short answers was produced and agreed on after the conference and was backed up by corresponding references

KW - risk factor

KW - disease

U2 - 10.1016/j.nut.2009.04.023

DO - 10.1016/j.nut.2009.04.023

M3 - Article

SN - 0899-9007

VL - 25

SP - 1202

EP - 1205

JO - Nutrition

JF - Nutrition

IS - 11-12

ER -

Bioactive compounds: Definition and assessment of activity

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this